Jundishapur Journal of Microbiology

Published by: Kowsar

Prevalence of Hepatitis G Virus Among Hemodialysis and Kidney Transplant Patients in Khuzestan Province, Iran

Ali Reza Samarbaf-Zadeh 1 , 2 , Manochehr Makvandi 1 , 2 , Ahmad Hamadi 3 , Gholam Abbas Kaydani 1 , 4 , * , Abdorrahim Absalan 5 , Parviz Afrough 6 , Mohammad Jahangir 1 , 2 and Saeid Saeidimehr 7
Authors Information
1 Health Research Institute, Infectious and Tropical Diseases Research Center, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, IR Iran
2 Virology Department, School of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, IR Iran
3 Department of Parasitology, Iran University of Medical Sciences, Tehran, IR Iran
4 Allied Health Sciences School, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, IR Iran
5 Department of Clinical Biochemistry, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, IR Iran
6 Department of Microbiology, Tehran University of Medical Sciences, Tehran, IR Iran
7 Department of Clinical Laboratory, Naft Grand Hospital, Ahvaz, IR Iran
Article information
  • Jundishapur Journal of Microbiology: May 01, 2015, 8 (5); e20834
  • Published Online: May 21, 2015
  • Article Type: Research Article
  • Received: May 31, 2014
  • Revised: October 7, 2014
  • Accepted: January 6, 2015
  • DOI: 10.5812/jjm.20834

To Cite: Samarbaf-Zadeh A R, Makvandi M, Hamadi A, Kaydani G A, Absalan A, et al. Prevalence of Hepatitis G Virus Among Hemodialysis and Kidney Transplant Patients in Khuzestan Province, Iran, Jundishapur J Microbiol. 2015 ; 8(5):e20834. doi: 10.5812/jjm.20834.

Abstract
Copyright © 2015, Ahvaz Jundishapur University of Medical Sciences. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Patients and Methods
4. Results
5. Discussion
Acknowledgements
Footnotes
References
  • 1. Francki RIB, Fauquet C, Knudson DL, Brown F. Classification and nomenclature of viruses. 1991;
  • 2. Westaway EG, Brinton MA, Gaidamovich S, Horzinek MC, Igarashi A, Kaariainen L, et al. Flaviviridae. Intervirology. 1985; 24(4): 183-92[PubMed]
  • 3. Gubler DJ, Meltzer M. Impact of dengue/dengue hemorrhagic fever on the developing world. Adv Virus Res. 1999; 53: 35-70[PubMed]
  • 4. Monath TP. Japanese encephalitis--a plague of the Orient. N Engl J Med. 1988; 319(10): 641-3[PubMed]
  • 5. Haghbin M, Murphy ML, Tan CC, Clarkson BD, Thaler HT, Passe S, et al. A long-term clinical follow-up of children with acute lymphoblastic leukemia treated with intensive chemotherapy regimens. Cancer. 1980; 46(2): 241-52[PubMed]
  • 6. Westaway E. Replication of flaviviruses. The Togaviruses. 1980; : 531-81
  • 7. Mukaide M, Mijokami M, Orito E. There are three subtypes of GB virus C/Hepatitis G virus (HGV): geographic distribution and HGV RNA levels. Hepatology. 1996; 24
  • 8. Linnen J, Wages JJ, Zhang-Keck ZY, Fry KE, Krawczynski KZ, Alter H, et al. Molecular cloning and disease association of hepatitis G virus: a transfusion-transmissible agent. Science. 1996; 271(5248): 505-8[PubMed]
  • 9. Bogard M, Louvet M, Kamalodine T, Barbanel C. Determination of hepatitis G virus (HGV) status in dialyzed patients: prevalence and rate of co-infection with hepatitis C virus (HCV). Hepatology. 1996; 24
  • 10. Diamantis I, Bassetti S, Erb P, Ladewig D, Gyr K, Battegay M. High prevalence and coinfection rate of hepatitis G and C infections in intravenous drug addicts. J Hepatol. 1997; 26(4): 794-7[PubMed]
  • 11. Feucht HH, Zollner B, Polywka S, Laufs R. Vertical transmission of hepatitis G. Lancet. 1996; 347(9001): 615-6[PubMed]
  • 12. Forns X, Fernandez-Llama P, Costa J, Lopez-Labrador FX, Ampurdanes S, Olmedo E, et al. Hepatitis G virus infection in a haemodialysis unit: prevalence and clinical implications. Nephrol Dial Transplant. 1997; 12(5): 956-60[PubMed]
  • 13. Moaven LD, Tennakoon PS, Bowden DS, Locarnini SA. Mother-to-baby transmission of hepatitis G virus. Med J Aust. 1996; 165(2): 84-5[PubMed]
  • 14. Peterson J, Zheng J, Fong T, Kim J, Kochesky R, Bolta R. Prevalence and persistence of hepatitis G virus in high risk populations. Hepatology. 1996; 24
  • 15. Sathar MA, Soni PN, Naicker S, Conradie J, Lockhat F, Gouws E. GB virus C/hepatitis G virus infection in KwaZulu Natal, South Africa. J Med Virol. 1999; 59(1): 38-44[PubMed]
  • 16. Noguchi S, Sata M, Suzuki H, Ohba K, Mizokami M, Tanikawa K. GB virus C (GBV-C)/hepatitis G virus (HGV) infection among intravenous drug users in Japan. Virus Res. 1997; 49(2): 155-62[PubMed]
  • 17. Pawlotsky JM, Roudot-Thoraval F, Muerhoff AS, Pellerin M, Germanidis G, Desai SM, et al. GB virus C (GBV-C) infection in patients with chronic hepatitis C. Influence on liver disease and on hepatitis virus behaviour: effect of interferon alfa therapy. J Med Virol. 1998; 54(1): 26-37[PubMed]
  • 18. De Filippi F., Lampertico P., Soffredini R., Rumi MG., Lunghi G., Aroldi A., et al. . High prevalence, low pathogenicity in hepatitis G virus in kidney transplant recipients Digest Liver Dis. 2001; 33(6): 477-9
  • 19. Heringlake S, Osterkamp S, Trautwein C, Tillmann HL, Boker K, Muerhoff S, et al. Association between fulminant hepatic failure and a strain of GBV virus C. Lancet. 1996; 348(9042): 1626-9[PubMed]
  • 20. Watanabe MA, Milanezi CM, Silva WA J, de Lucena Angulo I, Santis G, Kashima S, et al. Molecular investigation og GB virus C RNA in hemodialysis and thalassemics patients from Brazil. Ren Fail. 2003; 25(1): 67-75
  • 21. Okuda M, Hino K, Korenaga M, Yamaguchi Y, Kao Y, Mukaide M, et al. GB virus C/hepatic G viremia and antibody response to the E2 protein of hepatitis G virus in hemodialysis patients. J Clin Gastroenterol. 2000; 30: 425-8
  • 22. Kao, JH. , Huang, CH. , Chen, W. , Tsai, TJ. , et al. . GB virus C infection in hemodialysis patients: molecular evidence for nosocomial transmission. Infect Dis J. 1999; 180(1): 191-4
  • 23. Tameda Y, Kosaka Y, Tagawa S, Takase K, Sawada N, Nakao H, et al. Infection with GB virus C (GBV-C) in patients with fulminant hepatitis. J Hepatol. 1996; 25(6): 842-7[PubMed]
  • 24. Dawson GJ, Schlauder GG, Pilot-Matias TJ, Thiele D, Leary TP, Murphy P, et al. Prevalence studies of GB virus-C infection using reverse transcriptase-polymerase chain reaction. J Med Virol. 1996; 50(1): 97-103[PubMed]
  • 25. Hadziyannis SJ. Fulminant hepatitis and the new G/GBV-C flavivirus. J Viral Hepat. 1998; 5(1): 15-9[PubMed]
  • 26. Yoshiba M, Inoue K, Sekiyama K, Koh I. Favorable effect of new artificial liver support on survival of patients with fulminant hepatic failure. Artif Organs. 1996; 20(11): 1169-72[PubMed]
  • 27. Theodore D, Lemon SM. GB virus C, hepatitis G virus, or human orphan flavivirus? Hepatology. 1997; 25(5): 1285-6[DOI][PubMed]
  • 28. Simmonds P, Davidson F, Lycett C, Prescott LE, MacDonald DM, Ellender J, et al. Detection of a novel DNA virus (TTV) in blood donors and blood products. Lancet. 1998; 352(9123): 191-5[PubMed]
  • 29. Kafi-Abad SA, , Samiei S, , Talebian A, , Maghsudloo M, , Gharehbaghian A. . Hepatitis G virus infection in Iranian blood donors and high-risk groups. Hepat Mon J. 2009; 9(4): 282-6
  • 30. Samadi M, Keyvani H, Hosseini Moghaddam. SM. . Prevalence and risk factors of the hepatitis G (HGV) infection in hemodialysis patients. Arch Clinic Infect Dis. 2008; 3(1): 7-11
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments